Lipotecan Based Concurrent Chemoradiotherapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis

NCT03035006 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
1
Enrollment
INDUSTRY
Sponsor class

Stopped Current study design couldn't support futher development on this indication.

Conditions

Interventions

Sponsor

Taiwan Liposome Company